JHL Becomes Eden And Announces Denosumab Progress

Offers Phase I And III Updates On Biosimilar Rival To Amgen’s Prolia

 
• By David Wallace
  
Prolia Denosumab Amgen
Eden Biologics is readying a biosimilar rival to Prolia • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products